This week, we provide top-five ranked VE data for our Medical Sector stocks, take a look at General Electric $GE, and provide a free download link for our stock report on the company.
VALUATION WATCH: Overvalued stocks now make up 43.61% of our stocks assigned a valuation and 17.94% of those equities are calculated to be overvalued by 20% or more. Seven sectors are calculated to be overvalued.
ValuEngine Index Overview
| Index | Week Open | Friday PM | Change | % Change | YTD |
| DJIA | 25261.47 | 25934.78 | 673.31 | 2.67% | 4.92% |
| NASDAQ | 7344.08 | 7369.45 | 25.37 | 0.35% | 6.75% |
| RUSSELL 2000 | 1548.34 | 1544.66 | -3.68 | -0.24% | 0.60% |
| S&P 500 | 2726.37 | 2770.9 | 44.53 | 1.63% | 3.64% |
ValuEngine Market Overview
| Summary of VE Stock Universe | |
| Stocks Undervalued | 56.39% |
| Stocks Overvalued | 43.61% |
| Stocks Undervalued by 20% | 22.63% |
| Stocks Overvalued by 20% | 17.94% |
ValuEngine Sector Overview
| Sector | Change | MTD | YTD | Valuation | Last 12-MReturn | P/E Ratio |
| Medical | 0.16% | 4.53% | 15.14% | 10.75% overvalued | 29.55% | 28.38 |
| Aerospace | -0.34% | 3.35% | 1.45% | 8.21% overvalued | 6.15% | 25.21 |
| Computer and Technology | -0.32% | 3.61% | 2.53% | 7.93% overvalued | 10.76% | 29.40 |
| Utilities | -0.60% | 2.71% | 4.57% | 6.70% overvalued | -3.07% | 20.27 |
| Consumer Staples | -0.59% | 2.51% | -0.08% | 5.66% overvalued | 4.74% | 23.90 |
| Retail-Wholesale | 0.10% | 4.40% | -0.24% | 3.61% overvalued | 22.80% | 22.93 |
| Business Services | -0.14% | 2.67% | 6.91% | 1.18% overvalued | 7.25% | 22.32 |
| Consumer Discretionary | -0.54% | 1.92% | -4.19% | 0.81% undervalued | 11.09% | 24.41 |
| Transportation | -0.79% | 1.48% | -3.98% | 1.51% undervalued | -0.87% | 18.02 |
| Finance | -0.22% | 2.60% | -2.62% | 1.74% undervalued | -0.72% | 16.31 |
| Industrial Products | 0.14% | 4.35% | -5.45% | 2.03% undervalued | 2.68% | 22.42 |
| Multi-Sector Conglomerates | -1.33% | 2.22% | -10.82% | 2.70% undervalued | -8.79% | 17.42 |
| Auto-Tires-Trucks | -0.78% | 4.13% | -12.00% | 8.72% undervalued | -16.34% | 11.30 |
| Basic Materials | -0.89% | 1.77% | -6.27% | 9.72% undervalued | -10.60% | 19.11 |
| Construction | -0.39% | 3.88% | -7.48% | 12.23% undervalued | -8.76% | 18.68 |
| Oils-Energy | -1.86% | 1.23% | 0.63% | 20.72% undervalued | -1.36% | 20.15 |
Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE
Sector Talk–Medical
Below, we present the latest data on Medical stocks from our Professional Stock Analysis Service. Top- five lists are provided for each category. We applied some basic liquidity criteria–share price greater than $3 and average daily volume in excess of 100k shares.
Top-Five Medical Stocks–Short-Term Forecast Returns
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| CYH | COMMNTY HLTH SY | 3.84 | 300.00% | N/A |
| FATE | FATE THERAPEUTC | 13.59 | 165.62% | 196.08% |
| ATRA | ATARA BIOTHERP | 37.83 | 92.87% | 163.62% |
| ALDX | ALDEYRA THERAPT | 11 | 78.17% | 89.66% |
| TNDM | TANDEM DIABETES | 39.09 | 300.00% | 1451.19% |
Top-Five Medical Stocks–Momentum
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| TNDM | TANDEM DIABETES | 39.09 | 300.00% | 1451.19% |
| VKTX | VIKING THERAPTC | 13.14 | 106.50% | 511.16% |
| AMRN | AMARIN CORP PLC | 21.3 | 300.00% | 503.40% |
| PRQR | PROQR THERAP | 20.52 | 142.22% | 466.07% |
| CDNA | CAREDX INC | 27.74 | 102.92% | 406.20% |
Top-Five Medical Stocks–Composite Score
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| TEVA | TEVA PHARM ADR | 23.84 | 42.79% | 101.52% |
| ESRX | EXPRESS SCRIPTS | 99.32 | 21.54% | 62.02% |
| HCA | HCA HOLDINGS | 141.63 | 27.15% | 79.60% |
| MNK | MALLINCKRODT PL | 31.17 | -41.37% | 56.01% |
| BHC | BAUSCH HEALTH | 27.29 | -10.96% | 83.40% |
Top-Five Medical Stocks–Most Overvalued
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| MDGL | MADRIGAL PHARMA | 191.59 | 300.00% | 333.76% |
| CYH | COMMNTY HLTH SY | 3.84 | 300.00% | N/A |
| AMRN | AMARIN CORP PLC | 21.3 | 300.00% | 503.40% |
| EXAS | EXACT SCIENCES | 76.08 | 300.00% | 25.73% |
| TNDM | TANDEM DIABETES | 39.09 | 300.00% | 1451.19% |
Free Download for Readers
As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports
General Electric Company (GE) operates as a technology and financial services company. Its segments include Energy Infrastructure, Aviation, Healthcare, Transportation, Home & Business Solutions and GE Capital. The company’s Energy Infrastructure segment offers wind turbines; gas and steam turbines and generators. Its Aviation segment offers jet engines, turboprop and turbo shaft engines, aerospace systems and equipment. Its Healthcare segment provides medical imaging and information technologies, medical diagnostics, patient monitoring systems. Its Transportation segment provides drive technology solutions to various industries. Its Home and Business Solutions segment provides home appliances; lighting products, plant automation, hardware, software, and embedded computing systems. Its GE Capital segment offers commercial loans and leases, fleet management, financial programs, credit cards, personal loans and other financial services. General Electric Company is headquartered in Fairfield, Connecticut.
VALUENGINE RECOMMENDATION: ValuEngine continues its STRONG SELL recommendation on GENL ELECTRIC for 2018-11-08. Based on the information we have gathered and our resulting research, we feel that GENL ELECTRIC has the probability to UNDERPERFORM average market performance for the next year. The company exhibits UNATTRACTIVE Momentum and Sharpe Ratio.
You can download a free copy of detailed report on General Electric Company (GE) from the link below.
Read our Complete Rating and Forecast Report HERE.
| ValuEngine Forecast | ||
| Target Price* |
Expected Return |
|
|---|---|---|
| 1-Month | 8.99 | -1.18% |
| 3-Month | 8.93 | -1.85% |
| 6-Month | 8.61 | -5.40% |
| 1-Year | 7.81 | -14.17% |
| 2-Year | 8.88 | -2.42% |
| 3-Year | 9.37 | 2.98% |
| Valuation & Rankings | |||
| Valuation | 19.00% undervalued | Valuation Rank(?) | 77 |
| 1-M Forecast Return | -1.18% | 1-M Forecast Return Rank | 3 |
| 12-M Return | -54.77% | Momentum Rank(?) | 3 |
| Sharpe Ratio | -0.95 | Sharpe Ratio Rank(?) | 8 |
| 5-Y Avg Annual Return | -19.02% | 5-Y Avg Annual Rtn Rank | 23 |
| Volatility | 20.00% | Volatility Rank(?) | 68 |
| Expected EPS Growth | 0.90% | EPS Growth Rank(?) | 22 |
| Market Cap (billions) | 91.52 | Size Rank | 99 |
| Trailing P/E Ratio | 12.35 | Trailing P/E Rank(?) | 80 |
| Forward P/E Ratio | 12.24 | Forward P/E Ratio Rank | 61 |
| PEG Ratio | 13.65 | PEG Ratio Rank | 2 |
| Price/Sales | 0.76 | Price/Sales Rank(?) | 74 |
| Market/Book | 1.91 | Market/Book Rank(?) | 53 |
| Beta | 0.95 | Beta Rank | 42 |
| Alpha | -0.74 | Alpha Rank | 5 |
ValuEngine.com is an Independent Research Provider (IRP), producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Contact ValuEngine at (321) 325-0519 or support@valuengine.com
Visit www.ValuEngine.com for more information
ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuEngine’s award-winning stock research.
Contact ValuEngine Capital at info@valuenginecapital.com
Visit www.ValuEngineCapital.com for more information
Steve Hach
Senior Editor
ValuEngine.com